Subchronic effects of eszopiclone (Lunesta) on pain behavior and circuitry in primary insomnia
Phase of Trial: Phase IV
Latest Information Update: 28 Oct 2015
At a glance
- Drugs Eszopiclone (Primary)
- Indications Insomnia
- Focus Pharmacodynamics
- 23 Oct 2015 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 03 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Jan 2007 New trial record.